Literature DB >> 29059511

New biologics in psoriasis - progress and problems.

W-H Boehncke1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29059511     DOI： 10.1111/jdv.14576

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  2 in total

1.  Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain.

Authors:  Erin Johansson; Mercedes Nuñez; Axel Svedbom; Tatiana Dilla; Susanne Hartz
Journal:  Clinicoecon Outcomes Res       Date:  2018-11-12

2.  MicroRNA let-7b inhibits keratinocyte differentiation by targeting IL-6 mediated ERK signaling in psoriasis.

Authors:  Yan Wu; Liu Liu; Chunxiang Bian; Qingchun Diao; Muhammad Farrukh Nisar; Xuemei Jiang; Jörg W Bartsch; Maojiao Zhong; Xiangyu Hu; Julia Li Zhong
Journal:  Cell Commun Signal       Date:  2018-09-15       Impact factor: 5.712
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.